Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

Mantle cell lymphoma (MCL) is an incurable disease with a highly variable clinical course. The prognosis after relapse is generally poor, and no standard of care exists. We investigated the postrelapse outcomes of 149 patients who were initially treated in the Nordic Lymphoma Group trials, MCL2 or M...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Hemasphere
Main Authors: Eskelund, Christian Winther, Dimopoulos, Kostas, Kolstad, Arne, Glimelius, Ingrid, Räty, Riikka, Gjerdrum, Lise Mette Rahbek, Sonnevi, Kristina, Josefsson, Pär, Nilsson-Ehle, Herman, Bentzen, Hans H. N., Fagerli, Unn Merete, Kuittinen, Outi, Haaber, Jacob, Niemann, Carsten Utoft, Pedersen, Lone Bredo, Larsen, Maria Torp, Geisler, Christian Hartmann, Hutchings, Martin, Jerkeman, Mats, Grønbæk, Kirsten
Format: Artigo
Sprog:Inglês
Udgivet: Lippincott Williams & Wilkins 2020
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7755521/
https://ncbi.nlm.nih.gov/pubmed/33364550
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000510
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker